Ascendis Pharma A/S SEC filings ASND

Ascendis Pharma A/S has 796 filings in SEC EDGAR's recent list, going back to Aug 1, 2014. Its latest annual report, Form 20-F, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Feb 11, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Feb 12, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Feb 7, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Feb 16, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 2, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 10, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 3, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Apr 3, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 28, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 22, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Apr 15, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Mar 26, 2015 Dec 31, 2014

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ASND (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Denmark
Headquarters
Hellerup
SEC filer status
Large accelerated filer
SEC CIK
1612042

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.